Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen

Koji Izumi, Yi Li, Hitoshi Ishiguro, Yichun Zheng, Jorge L. Yao, George J. Netto, Hiroshi Miyamoto

Research output: Contribution to journalArticle

Abstract

Although UDP-glucuronosyltransferase 1A (UGT1A) plays an important role in preventing bladder cancer initiation by detoxifying carcinogenic compounds, its contribution to bladder cancer progression is poorly understood. We immunohistochemically stained for UGT1A in bladder specimens. UGT1A was positive in 130/145 (90%; 28 [19%] weak, 53 [37%] moderate, and 49 [34%] strong) urothelial neoplasms, which was significantly weaker than in matched non-neoplastic urothelial tissues (100/101 [99%]; 2 [2%] weak, 17 [17%] moderate, and 81 [80%] strong). Fifty (98%) of 51 low-grade/79 (99%) of 80 non-muscle-invasive tumors were immunoreactive to UGT1A, whereas 80 (85%) of 94 high-grade/51 (78%) of 65 muscle-invasive tumors were UGT1A-positive. Kaplan-Meier analysis showed strong associations between lower UGT1A expression versus the risk of recurrence in high-grade non-muscle-invasive tumors (P=0.038) or disease-specific mortality in muscle-invasive tumors (P=0.016). Multivariate analysis further revealed UGT1A loss as an independent prognosticator for disease-specific mortality in patients with muscle-invasive tumor (P=0.010). Additionally, the expression of UGT1A was positively and negatively correlated with those of estrogen receptor-α and estrogen receptor-β, respectively. We then assessed UGT1A/Ugt1a levels in human cell lines/mouse tissues. 17β-Estradiol increased and decreased UGT1A expression in normal urothelium and bladder cancer lines, respectively, and an anti-estrogen abolished these effects. Ovariectomy in mice resulted in down-regulation of Ugt1a subtypes. These results suggest the involvement of UGT1A in not only bladder carcinogenesis but tumor progression. Moreover, UGT1A is likely regulated by estrogens in non-neoplastic urothelium versus bladder tumor in opposite manners, which could be underlying mechanisms of gender-specific differences in bladder cancer incidence and progression.

Original languageEnglish (US)
Pages (from-to)314-324
Number of pages11
JournalMolecular Carcinogenesis
Volume53
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Glucuronosyltransferase
Urinary Bladder Neoplasms
Estrogens
Urothelium
Neoplasms
Estrogen Receptors
Muscles
Mortality
Kaplan-Meier Estimate
Ovariectomy
Estradiol
Carcinogenesis
Urinary Bladder
Down-Regulation
Multivariate Analysis

Keywords

  • 17β-estradiol
  • Immunohistochemistry
  • Ovariectomy
  • SVHUC cell line
  • Urothelial neoplasm

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Expression of UDP-glucuronosyltransferase 1A in bladder cancer : Association with prognosis and regulation by estrogen. / Izumi, Koji; Li, Yi; Ishiguro, Hitoshi; Zheng, Yichun; Yao, Jorge L.; Netto, George J.; Miyamoto, Hiroshi.

In: Molecular Carcinogenesis, Vol. 53, No. 4, 2014, p. 314-324.

Research output: Contribution to journalArticle

Izumi, Koji ; Li, Yi ; Ishiguro, Hitoshi ; Zheng, Yichun ; Yao, Jorge L. ; Netto, George J. ; Miyamoto, Hiroshi. / Expression of UDP-glucuronosyltransferase 1A in bladder cancer : Association with prognosis and regulation by estrogen. In: Molecular Carcinogenesis. 2014 ; Vol. 53, No. 4. pp. 314-324.
@article{e9caea68a9694fe4ba151f6163fd2ade,
title = "Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen",
abstract = "Although UDP-glucuronosyltransferase 1A (UGT1A) plays an important role in preventing bladder cancer initiation by detoxifying carcinogenic compounds, its contribution to bladder cancer progression is poorly understood. We immunohistochemically stained for UGT1A in bladder specimens. UGT1A was positive in 130/145 (90{\%}; 28 [19{\%}] weak, 53 [37{\%}] moderate, and 49 [34{\%}] strong) urothelial neoplasms, which was significantly weaker than in matched non-neoplastic urothelial tissues (100/101 [99{\%}]; 2 [2{\%}] weak, 17 [17{\%}] moderate, and 81 [80{\%}] strong). Fifty (98{\%}) of 51 low-grade/79 (99{\%}) of 80 non-muscle-invasive tumors were immunoreactive to UGT1A, whereas 80 (85{\%}) of 94 high-grade/51 (78{\%}) of 65 muscle-invasive tumors were UGT1A-positive. Kaplan-Meier analysis showed strong associations between lower UGT1A expression versus the risk of recurrence in high-grade non-muscle-invasive tumors (P=0.038) or disease-specific mortality in muscle-invasive tumors (P=0.016). Multivariate analysis further revealed UGT1A loss as an independent prognosticator for disease-specific mortality in patients with muscle-invasive tumor (P=0.010). Additionally, the expression of UGT1A was positively and negatively correlated with those of estrogen receptor-α and estrogen receptor-β, respectively. We then assessed UGT1A/Ugt1a levels in human cell lines/mouse tissues. 17β-Estradiol increased and decreased UGT1A expression in normal urothelium and bladder cancer lines, respectively, and an anti-estrogen abolished these effects. Ovariectomy in mice resulted in down-regulation of Ugt1a subtypes. These results suggest the involvement of UGT1A in not only bladder carcinogenesis but tumor progression. Moreover, UGT1A is likely regulated by estrogens in non-neoplastic urothelium versus bladder tumor in opposite manners, which could be underlying mechanisms of gender-specific differences in bladder cancer incidence and progression.",
keywords = "17β-estradiol, Immunohistochemistry, Ovariectomy, SVHUC cell line, Urothelial neoplasm",
author = "Koji Izumi and Yi Li and Hitoshi Ishiguro and Yichun Zheng and Yao, {Jorge L.} and Netto, {George J.} and Hiroshi Miyamoto",
year = "2014",
doi = "10.1002/mc.21978",
language = "English (US)",
volume = "53",
pages = "314--324",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Expression of UDP-glucuronosyltransferase 1A in bladder cancer

T2 - Association with prognosis and regulation by estrogen

AU - Izumi, Koji

AU - Li, Yi

AU - Ishiguro, Hitoshi

AU - Zheng, Yichun

AU - Yao, Jorge L.

AU - Netto, George J.

AU - Miyamoto, Hiroshi

PY - 2014

Y1 - 2014

N2 - Although UDP-glucuronosyltransferase 1A (UGT1A) plays an important role in preventing bladder cancer initiation by detoxifying carcinogenic compounds, its contribution to bladder cancer progression is poorly understood. We immunohistochemically stained for UGT1A in bladder specimens. UGT1A was positive in 130/145 (90%; 28 [19%] weak, 53 [37%] moderate, and 49 [34%] strong) urothelial neoplasms, which was significantly weaker than in matched non-neoplastic urothelial tissues (100/101 [99%]; 2 [2%] weak, 17 [17%] moderate, and 81 [80%] strong). Fifty (98%) of 51 low-grade/79 (99%) of 80 non-muscle-invasive tumors were immunoreactive to UGT1A, whereas 80 (85%) of 94 high-grade/51 (78%) of 65 muscle-invasive tumors were UGT1A-positive. Kaplan-Meier analysis showed strong associations between lower UGT1A expression versus the risk of recurrence in high-grade non-muscle-invasive tumors (P=0.038) or disease-specific mortality in muscle-invasive tumors (P=0.016). Multivariate analysis further revealed UGT1A loss as an independent prognosticator for disease-specific mortality in patients with muscle-invasive tumor (P=0.010). Additionally, the expression of UGT1A was positively and negatively correlated with those of estrogen receptor-α and estrogen receptor-β, respectively. We then assessed UGT1A/Ugt1a levels in human cell lines/mouse tissues. 17β-Estradiol increased and decreased UGT1A expression in normal urothelium and bladder cancer lines, respectively, and an anti-estrogen abolished these effects. Ovariectomy in mice resulted in down-regulation of Ugt1a subtypes. These results suggest the involvement of UGT1A in not only bladder carcinogenesis but tumor progression. Moreover, UGT1A is likely regulated by estrogens in non-neoplastic urothelium versus bladder tumor in opposite manners, which could be underlying mechanisms of gender-specific differences in bladder cancer incidence and progression.

AB - Although UDP-glucuronosyltransferase 1A (UGT1A) plays an important role in preventing bladder cancer initiation by detoxifying carcinogenic compounds, its contribution to bladder cancer progression is poorly understood. We immunohistochemically stained for UGT1A in bladder specimens. UGT1A was positive in 130/145 (90%; 28 [19%] weak, 53 [37%] moderate, and 49 [34%] strong) urothelial neoplasms, which was significantly weaker than in matched non-neoplastic urothelial tissues (100/101 [99%]; 2 [2%] weak, 17 [17%] moderate, and 81 [80%] strong). Fifty (98%) of 51 low-grade/79 (99%) of 80 non-muscle-invasive tumors were immunoreactive to UGT1A, whereas 80 (85%) of 94 high-grade/51 (78%) of 65 muscle-invasive tumors were UGT1A-positive. Kaplan-Meier analysis showed strong associations between lower UGT1A expression versus the risk of recurrence in high-grade non-muscle-invasive tumors (P=0.038) or disease-specific mortality in muscle-invasive tumors (P=0.016). Multivariate analysis further revealed UGT1A loss as an independent prognosticator for disease-specific mortality in patients with muscle-invasive tumor (P=0.010). Additionally, the expression of UGT1A was positively and negatively correlated with those of estrogen receptor-α and estrogen receptor-β, respectively. We then assessed UGT1A/Ugt1a levels in human cell lines/mouse tissues. 17β-Estradiol increased and decreased UGT1A expression in normal urothelium and bladder cancer lines, respectively, and an anti-estrogen abolished these effects. Ovariectomy in mice resulted in down-regulation of Ugt1a subtypes. These results suggest the involvement of UGT1A in not only bladder carcinogenesis but tumor progression. Moreover, UGT1A is likely regulated by estrogens in non-neoplastic urothelium versus bladder tumor in opposite manners, which could be underlying mechanisms of gender-specific differences in bladder cancer incidence and progression.

KW - 17β-estradiol

KW - Immunohistochemistry

KW - Ovariectomy

KW - SVHUC cell line

KW - Urothelial neoplasm

UR - http://www.scopus.com/inward/record.url?scp=84895819724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895819724&partnerID=8YFLogxK

U2 - 10.1002/mc.21978

DO - 10.1002/mc.21978

M3 - Article

C2 - 23143693

AN - SCOPUS:84895819724

VL - 53

SP - 314

EP - 324

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 4

ER -